Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [02/25/2020 07:36 PST] CTXR Expected to Trade Up After Bullish Patterns Develop
• [02/18/2020 07:18 PST] CTXR Expected to Trade Up Short Term
• [02/14/2020 11:45 PST] Citius Pharmaceuticals, Inc. (NASDAQ:CTXR), Up By 100.00% ($1.07) From $1.070 After BUYINS.NET Report Predicted Stock Would Go Up Due To Bullish Conditions
• [02/11/2020 07:22 PST] CTXR Expected to Trade Up Short Term
• [02/07/2020 07:20 PST] CTXR Expected to Trade Up After Bullish Patterns Develop
• [01/30/2020 07:43 PST] CTXR Expected to Trade Up Short Term
• [01/24/2020 07:30 PST] CTXR Expected to Trade Up After Bullish Patterns Develop
• [01/22/2020 21:17 PST] Market Maker Surveillance Report. CTXR, Winning Stocks With Lowest Price Friction For Wednesday, January 22nd 2020
• [01/22/2020 07:49 PST] CTXR Expected to Trade Down After Bearish Patterns Develop
• [01/03/2020 07:57 PST] CTXR Expected to Trade Down After Bearish Patterns Develop
• [12/26/2019 21:17 PST] Market Maker Surveillance Report. CTXR, Winning Stocks With Lowest Price Friction For Thursday, December 26th 2019